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Abstract
Background—Enhanced HIV surveillance using demographic, behavioral, and biologic data 
from national surveys can provide information to evaluate and respond to HIV epidemics 
efficiently.
Methods—From October 2012 to February 2013, we conducted a 2-stage cluster sampling 
survey of persons aged 18 months to 64 years in 9 geographic regions in Kenya. Participants 
answered questionnaires and provided blood for HIV testing. We estimated HIV prevalence, HIV 
incidence, described trends in HIV prevalence over the past 5 years, and identified factors 
associated with HIV infection. This analysis was restricted to persons aged 15–64 years.
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Results—HIV prevalence was 5.6% [95% confidence interval (CI): 4.9 to 6.3] in 2012, a 
significant decrease from 2007, when HIV prevalence, excluding the North Eastern region, was 
7.2% (95% CI: 6.6 to 7.9). HIV incidence was 0.5% (95% CI: 0.2 to 0.9) in 2012. Among women, 
factors associated with undiagnosed HIV infection included being aged 35–39 years, divorced or 
separated, from urban residences and Nyanza region, self-perceiving a moderate risk of HIV 
infection, condom use with the last partner in the previous 12 months, and reporting 4 or more 
lifetime number of partners. Among men, widowhood, condom use with the last partner in the 
previous 12 months, and lack of circumcision were associated with undiagnosed HIV infection.
Conclusions—HIV prevalence has declined in Kenya since 2007. With improved access to 
treatment, HIV prevalence has become more challenging to interpret without data on new 
infections and mortality. Correlates of undiagnosed HIV infection provide important information 
on where to prioritize prevention interventions to reduce transmission of HIV in the broader 
population.
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INTRODUCTION
HIV continues to be a major public health challenge in sub-Saharan Africa, where an 
estimated 22 million people are living with HIV.1 In a population of 40 million in Kenya, 
1.6 million people of all ages were living with HIV in 2012 and an estimated 98,000 of these 
had acquired HIV infection within the preceding year, making Kenya’s HIV epidemic the 
fourth largest worldwide.1,2 For this reason, Kenya has been regarded globally as a priority 
country in sub-Saharan Africa to reverse the spread of HIV in the region.
To implement effective HIV programs, nationally representative data that reflect the 
country’s current HIV epidemiology are required. Since 2003, HIV testing has been 
included in national household surveys, including the Kenya Demographic and Health 
Surveys (2003 and 2008–09) and the Kenya AIDS Indicator Survey (KAIS) in 2007.3–5 
These surveys estimated that HIV prevalence in adults ranged from 6.3% to 7.4%. Data 
from these surveys have provided a clearer understanding of the magnitude, distribution, and 
trends in HIV infection, as well as coverage of HIV treatment and prevention interventions 
to inform policies and programs to address the epidemic.6
We conducted a second Kenya AIDS Indicator Survey (KAIS 2012) to estimate HIV 
incidence and prevalence, assess trends in HIV prevalence since 2007, and identify factors 
associated with HIV infection to inform programmatic and policy decisions to guide the 
national HIV response for the next five years in Kenya.
METHODS
KAIS 2012 was a cross-sectional household survey of persons aged 18 months to 64 years, 
conducted from October 2012 to February 2013. The methods of this survey are described in 
detail elsewhere.7 The survey was designed to provide representative estimates of HIV 
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prevalence among adults and adolescents aged 15 to 64 years at the national and regional 
level for the urban and rural populace. Among children aged 18 months to 14 years, the 
survey was powered to provide estimates of HIV prevalence at the national level only. 
Because of regional insecurity at the time of the survey, the North Eastern region was not 
sampled. For the purposes of this article, we restricted our analyses to adults and adolescents 
aged 15 to 64 years.
Data Collection Procedures
Interviewers conducted face-to-face interviews with eligible participants. Interviews 
collected information on individual demographic and behavioral characteristics. Interview 
data were entered directly into tablet computers (Mirus Innovations, Mississauga, Ontario, 
Canada). Participants provided venous blood for HIV testing, which was performed at a 
central laboratory in Nairobi. If venous blood could not be collected, a finger prick was used 
to collect a dried capillary blood spot sample for HIV testing. Participants were informed 
that they would not receive the results of their laboratory tests but were offered home-based 
HIV testing and counseling services using the national HIV testing algorithm8 if they 
wished to learn their HIV status in the privacy of their homes.
Laboratory Methods
At the central laboratory, the same validated HIV testing algorithm that was used in KAIS 
2007 was applied to KAIS 2012 blood samples. All specimens were initially screened with 
Vironostika HIV-1/2 UNIF II Plus O Enzyme Linked Immunoassay (bioMérieux, Marcy 
l’Etoile, France). Specimens that were reactive were then tested with the Murex HIV.1.2.O 
HIV Enzyme Immunoassay (DiaSorin, SpA, Saluggia, Italy) to confirm reactivity. 
Specimens with discrepant results were retested using the same algorithm. Twice discrepant 
results were resolved using polymerase chain reaction (Cobas Amplicor HIV-1 Monitor 
Test, version 1.5, Roche Molecular Diagnostics, Pleasanton, CA). HIV-positive dried blood 
spot specimens were tested for HIV RNA concentration using the Abbott M2000 Real-Time 
HIV-1 Assay (Abbott Laboratories, Abbott Park, IL) and recent HIV infection using the 
Limiting Antigen Avidity Enzyme Immunoassay (LAg-Avidity EIA) (Maxim Biomedical, 
Inc., Rockville, MD). Specimens with a normalized optical density value of 1.5 or lower on 
the LAg-Avidity EIA and (1) not virally suppressed (defined as HIV RNA concentration 
<1000 copies/mL) or (2) did not report use of antiretroviral therapy (ART) for their HIV 
infection were classified as indicative of recent infection. The estimated mean duration of 
recent infection for the assay was 130 days (95% confidence interval [CI] 118 to 142).
Data Management
We merged interview and laboratory data to produce a final survey data set for analysis. 
Survey data were weighted to correct for unequal probability of selection and adjusted for 
interview and blood nonresponse to produce estimates that were representative of the 
population from which the KAIS 2012 sample was drawn. All data were analyzed using 
SAS version 9.3 (SAS Institute, Cary, NC).
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We conducted univariate analyses and present frequencies and weighted proportions with 
95% CI. Statistical significance for cross-tabulations was assessed using the Rao–Scott χ2 
test. We assessed whether there were changes in HIV prevalence between KAIS 2007 and 
KAIS 2012 by age, sex, residence, and geographic region. A z-test was used to test for 
differences in proportions between the 2 surveys, and we considered a P value < 0.05 to be 
statistically significant.
Using the PROC SURVEYLOGISTIC procedure, we conducted bivariate and multivariate 
analyses to identify correlates of undiagnosed HIV infection among persons who had ever 
had sex and report results as odds ratios (OR), adjusted odds ratios (AOR), and 95% CI. We 
selected undiagnosed HIV infection as our main outcome of interest to identify 
subpopulations that were at the highest risk of acquiring and transmitting HIV infection. 
Predictor variables included the following: age, education, marital status, region, residence, 
household wealth, risk perception, condom use, number of sexual partners, lifetime history 
of high-risk behavior, including injecting drugs, anal sex, and transactional sex, symptoms 
of sexually transmitted infection (STI), self-reported circumcision among men, and 
circumcision status of male partners reported by women. Variables associated with 
undiagnosed HIV infection at P value <0.2 in bivariate analyses were tested in a multivariate 
model to identify factors that were independently associated with undiagnosed HIV 
infection. Variables that remained significantly associated with HIV infection at P value 
<0.05 were retained in the final model.
To estimate the number of adults and adolescents aged 15–64 years living with HIV and 
number with recently acquired HIV infection, we applied non-normalized survey weights to 
our HIV outcome variable. Non-normalized weights were based on the 2012 projected 
population data derived from the 2009 Kenya Population and Housing Census.2 Annualized 
HIV incidence was calculated using the World Health Organization’s recommended formula 
for estimating assay-based HIV incidence.9 The annual HIV transmission rate per 100 
persons living with HIV was calculated by dividing the estimated HIV incidence by the 
estimated HIV prevalence and multiplying this value by 100.10
This study was approved by the Kenya Medical Research Institute Ethical Review 
Committee, the Institutional Review Board of the US Centers for Disease Control and 
Prevention, and the Committee on Human Research of the University of California, San 
Francisco.
RESULTS
Eligibility and Characteristics of Study Population
Of the 16,383 persons eligible for the survey, 13,720 (83.7%) consented to an interview. 
Among the 13,720 individuals in the interview sample, 11,626 (84.7%) provided a blood 
sample, representing the serologic sample from which HIV prevalence was estimated. 
Compared with individuals in the interview sample, significantly higher proportions of 
individuals in the serologic sample were from rural residences (64.1% compared with 
56.4%, P = 0.003), from North Rift region (14.2% compared with 1.0%, P < 0.001), had 
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ever been widowed (6.1% compared with 5.5%, P = 0.002), and were women who had been 
pregnant in the past (78.8% compared with 73.5%, P < 0.001), respectively (Table 1). In 
addition, compared with persons in the interview sample, significantly higher proportions of 
persons in the serologic sample reported being sexually active in the past 12 months (72.3% 
compared with 68.1%, P = 0.003), perceived that their risk of HIV infection was great (5.0% 
compared with 3.3%, P = 0.005), had received their last HIV test more than 12 months 
preceding the survey (45.1% compared with 38.1%, P < 0.001), and self-reported HIV-
positive status based on their HIV testing history (4.1% compared with 2.1%, P < 0.001), 
respectively.
Among the 11,626 participants in the serologic sample, 51.3% were women. The median 
age was 33 years (interquartile range, 25–43). Over half (52.7%) had completed secondary 
school education or higher. The majority (64.1%) resided in rural areas; 14.7% were from 
Nyanza, 14.3% from Eastern South, 14.2% from North Rift, 9.8% from Nairobi, and 1.1% 
from Eastern North regions. Over half (57.5%) were currently in married or cohabiting 
relationships.
Most (87.4%) reported having ever had sexual intercourse, and 72.3% reported sexual 
intercourse in the past 12 months. Among these, 11.5% reported 2 or more partners in the 
past 12 months. Eighty-five percent of participants reported no to low self-perceived risk of 
HIV infection. Anal sex was reported by 1.9%. Receiving money, gifts, and favors in 
exchange for sex was reported by 3.8%. In total, 17.8% of men reported ever giving money, 
gifts, or favors in exchange for sex. Symptoms of STI in the past 12 months, including 
genital sores and/or vaginal (women only), penile (men only), or anal discharge were 
reported by 5.8% (2.7% of men and 8.7% of women). Among women, 78.8% had ever been 
pregnant, and 6.2% were currently pregnant at the time of the survey. Ninety-one percent of 
men were circumcised, and 70.1% of women reported that their current male partner was 
circumcised.
HIV Prevalence and Incidence
HIV prevalence was 5.6% (95% CI: 4.9 to 6.3), and HIV incidence was 0.5% (95% CI: 0.2 
to 0.9), corresponding to an annual HIV transmission rate of 8.9 per 100 HIV-infected 
persons. Regional differences in HIV prevalence were observed with the highest HIV 
prevalence noted in Nyanza region (15.1%, 95% CI: 11.4 to 18.8) and lowest in Eastern 
North region (2.1%, 95% CI: 1.0 to 3.2) (Table 2). Women had significantly higher HIV 
prevalence than men (6.9% vs. 4.4%; P < 0.0001). HIV prevalence increased with age, 
peaking at age 35–39 years among women (12.3%, 95% CI: 9.4 to 15.2) and age 45–54 
years among men (7.2%, 95% CI: 4.9 to 9.6) (data not shown). HIV prevalence was highest 
among persons who had been widowed (20.0%, 95% CI: 16.2 to 23.7), separated or 
divorced (10.9%, 95% CI: 8.4 to 13.4), or were married or cohabiting in a polygamous 
relationship (9.7%, 95% CI: 6.4 to 13.1).
Trends in HIV Prevalence, 2007–2012
HIV prevalence declined significantly from 7.2% (excluding North Eastern region) in 2007 
to 5.6% in 2012 (P = 0.002; Fig. 1). Significant declines were observed for both men (5.5% 
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in 2007 to 4.4% in 2012; P = 0.0310) and women (8.5% in 2007; 6.9% in 2012; P = 0.006) 
(data not shown). We observed differential changes in HIV prevalence across age groups. In 
2007, HIV prevalence peaked among persons aged 30–34 years (11.9%; 95% CI: 10.0 to 
13.5), while in 2012, HIV prevalence peaked among persons aged 45–49 years (9.8%, 95% 
CI: 7.1 to 12.5). HIV prevalence declined significantly for persons who were aged 15–34 
years in 2007 and 2012 (P ≤ 0.010) but remained unchanged among persons aged 35 years 
and older in the same time period.
In Table 3, we describe trends in HIV prevalence between 2007 and 2012 for select age 
groups by sex, geographic location, and residence. Among persons aged 15–24 years, we 
observed significant declines in HIV prevalence for women (5.6% in 2007 to 3.0% in 2012; 
P < 0.001) but not for men (1.0% in 2007 to 1.1% in 2012; P = 0.864). For women aged 15–
24 years, significant declines in HIV prevalence were observed among those residing in 
Nairobi (5.8% in 2007 to 1.8% in 2012; P = 0.038), Coast (5.7% in 2007 to 2.0% in 2012; P 
= 0.026), and Eastern (4.3%, in 2007 to 0.6% in 2012; P = 0.001) regions and those residing 
in rural areas (5.7% in 2007 to 2.8% in 2012; P < 0.001). Among men aged 15–24 years, 
significant declines in HIV prevalence were observed among those residing in Coast region 
(4.5% to 0.5%; P = 0.041) and rural areas (1.4% to 0.4%; P = 0.012).
Among persons aged 25–34 years, we observed declining HIV prevalence among men 
(8.1% in 2007 to 5.4% in 2012; P = 0.013) and women (12.0% in 2007 to 7.3% in 2012; P < 
0.001). Among women aged 25–34 years, significant declines were observed among those 
residing in Nairobi (14.0% to 6.6%; P = 0.002), Coast (11.6% to 4.1%; P = 0.005), and Rift 
Valley (11.2% to 4.0%; P = 0.003) regions and those residing in both rural (11.4% to 6.3%; 
P < 0.001) and urban (13.5% to 8.7%; P = 0.036) areas in 2007 and 2012, respectively. 
Among men aged 25–34 years, significant declines were observed in Coast region (7.1% in 
2007 to 0.6% in 2012; P = 0.002) and among persons residing in rural areas (8.0% in 2007 
to 4.9% in 2012; P = 0.033). Among persons aged 35 years and older, no changes in HIV 
prevalence were observed across sex and urban/rural residences between 2007 and 2012. 
HIV prevalence, however, increased significantly among women residing in Central region, 
from 3.1% in 2007 to 8.4% 2012 (P = 0.001).
Factors Associated With Undiagnosed HIV Infection
Of the 10,097 persons who had ever had sex, 6.3% (95% CI: 5.3 to 7.1) were HIV infected 
(Table 2); 52.2% (95% CI: 46.5 to 57.8) of these had undiagnosed HIV infection (data not 
shown). We compared individuals with undiagnosed HIV infection with those who were 
HIV uninfected to assess factors associated with undiagnosed HIV infection. Among men, 
factors that were independently associated with increased odds of undiagnosed HIV 
infection were widowhood (AOR: 8.1, 95% CI: 1.9 to 34.6, P = 0.005) and using a condom 
with the last sexual partner in the past year (AOR: 3.3, 95% CI: 1.8 to 6.2, P < 0.001) (Table 
4). In contrast, men who were circumcised had significantly lower odds of undiagnosed HIV 
infection (AOR: 0.3, 95% CI: 0.1 to 0.5, P < 0.001). Among women, higher odds of 
undiagnosed HIV infection were associated with being aged 34–39 years (AOR: 4.5, 95% 
CI: 1.1 to 18.3, P = 0.037), separated or divorced (AOR: 2.3, 95% CI: 1.1 to 5.0, P = 0.033), 
residence in Nyanza region (AOR: 2.9, 95% CI: 1.4 to 6.0, P = 0.004), living in urban areas 
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(AOR: 1.8, 95% CI: 1.1 to 2.7, P = 0.012), having a moderate self-perceived risk of HIV 
infection (AOR: 2.1, 95% CI: 1.3 to 3.5, P = 0.002), using a condom with the last sexual 
partner in the past year (AOR: 2.3, 95% CI: 1.2 to 4.2, P < 0.009), and reporting ≥ 4 lifetime 
number of sexual partners (AOR: 1.9, 95% CI: 1.1 to 3.4, P = 0.026).
DISCUSSION
This population-based survey provides an update on the status of the HIV epidemic in 
Kenya. HIV prevalence was 5.6% and HIV incidence was 0.5% among persons aged 15–64 
years. This represents approximately 1,192,000 million (95% CI: 1,037,000 to 1,347,000) 
adults and adolescents living with HIV in 2012, 106,000 (95% CI 32,000 to 180,000) of 
whom had recently acquired their HIV infection within the preceding year. These results 
broadly corroborate the 2012 estimates published by the Joint United Nations Programme on 
HIV/AIDS in 2013, which reported that the number of Kenyan adults and adolescents aged 
≥15 years living with HIV/AIDS in 2012 was 1,400,000 (lower estimate: 1,400,000; upper 
estimate: 1,500,000), and the number of new infections was 85,000 (lower estimate: 80,000; 
upper estimate: 96,000).1 Based on our results, the annual HIV transmission rate was 8.9 per 
100 persons living with HIV in 2012. In other words, 9% of all persons living with HIV in 
2012 were transmitting to HIV-negative persons. In comparison, the annual transmission 
rate in the United States, where 16% of the HIV-infected population remains undiagnosed, 
was 4.1 per 100 HIV-infected persons in 2010.10
Our data confirm a significant decline in HIV prevalence from 7.2% (excluding North 
Eastern region) in 2007 to 5.6% in 2012, with similar declines noted across male and female 
sex. Based on mathematically modeled HIV incidence in 2007, our results also suggest that 
HIV incidence may have declined from 0.7% in 2007 to 0.5% in 2012, coinciding with 
similar declines in new HIV infections reported by at least 26 countries in Africa, Asia, and 
the Caribbean between 2001 and 2012.1,11 Declining incidence is also supported by the 
observation that HIV prevalence reduced significantly among younger persons aged 15–34 
years between 2007 and 2012 but remained unchanged among older persons aged 35 years 
and above.
Among persons aged 15–34 years, we observed differential trends in HIV prevalence across 
geographic regions and sex, providing important epidemiologic evidence on sub-populations 
where substantial reductions in HIV infection may be occurring. Among women, declining 
prevalence was observed for women aged 15–34 years in Nairobi and Coast regions, women 
aged 15–24 years in Eastern region, and women aged 25–34 years in Rift Valley region. 
Among men, declining prevalence was observed among men aged 15–34 years in Coast 
region. Of concern, we found a significant increase in HIV prevalence among middle-aged 
and older women (aged ≥35 years) residing in Central region.
Reductions in HIV prevalence on a population level is possible if there are marked declines 
in new HIV infections or high rates of HIV-related death in a population. If substantial, both 
scenarios on their own could result in a diminished pool of infected people in the population. 
Over the past 5 years, Kenya has experienced substantial progress in linking HIV-infected 
persons into HIV care and placing those that require ART on treatment.12 Increased 
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coverage of ART and high levels of viral suppression on ART have led to significant 
reductions in HIV mortality and HIV transmission risk, likely contributing to a possible 
decline in HIV incidence over the past 5 years.1,12 Still, over half of HIV-infected persons in 
the country remained undiagnosed by the year-end (2012), representing a major barrier to 
achieving even greater reductions in HIV transmission to eventually halt the spread of 
infection.13 A critical component to reversing this trend will be to accelerate ART coverage 
in the country by prioritizing HIV testing in settings that will yield greater numbers of HIV-
infected persons, facilitating their immediate linkages into HIV care services, and treating 
them promptly.
Our findings provide important insight on groups with increased risk of transmitting HIV to 
sexual partners, highlighting opportunities for targeted HIV prevention. Markers of high-risk 
sexual behaviors, including multiple sexual partners and perceived risk of HIV infection 
were associated with higher odds of undiagnosed HIV infection. Surprisingly, we found that 
persons who used a condom with their last sexual partner in the past 12 months had higher 
odds of undiagnosed HIV infection. This positive association may be a reflection of 
reluctance or denial in admitting to unprotected sex. Alternatively, it could suggest that 
persons who choose to use condoms with their sexual partners may already know that they 
are at high risk of HIV infection despite lack of awareness of their HIV infection. The use of 
condoms in this group is an encouraging finding for HIV-positive prevention strategies but 
raises the question as to whether current condom use campaigns are effective in reaching the 
general population with messages on the important benefits of correct and consistent 
condom use for HIV prevention.
Widowhood has been previously described as a factor associated with HIV infection in 
Kenya and other countries in sub-Saharan Africa although the factors that place widowed 
men at higher risk of HIV infection are not clear-cut.14–18 Widowers whose spouses died of 
HIV disease may have been exposed to high viral load from their partners, which can occur 
during late-stage disease,17 but it is also possible that widowed men were sources of 
infection for their spouses who died from the disease. Studies have also demonstrated that 
widowers are more likely to engage in high-risk sexual behavior after the death of their 
spouse and contribute to new HIV infections in the population.15
In addition to widowhood, the link between HIV infection and divorce or separation in 
women sheds additional light on the vulnerability of women in the Kenyan HIV epidemic. 
Previous studies in sub-Saharan Africa have reported that the dissolution of marriage, 
through divorce or separation, is often the result of a female’s HIV status within the couple 
relationship. HIV-infected women in serodiscordant relationships are more likely to be 
separated or divorced than HIV-infected men in serodiscordant relationships, reinforcing the 
gender disparities that exist around sexual norms in the African context.18 Further 
exploration of the impact of serodiscordancy on marital outcomes and implications for the 
spread of HIV may help to understand how to appropriately strategize prevention, care, and 
treatment services for couples and formerly married individuals.
Male circumcision has been widely cited as a key pillar of HIV prevention that can 
significantly reduce new HIV infections in a population.19–21 Because of an aggressive 
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national strategy on male circumcision, which was implemented in 2008, Kenya has 
observed substantial increases in male circumcision over the past 5 years, increasing from 
85.0% in 2007 to 91.2% in 2012.11 Greatest increases were noted in the 4 priority regions 
for the national voluntary male medical circumcision program: Nairobi, Nyanza, Rift 
Valley, and Western regions.11 However, coverage in traditionally noncircumcising 
communities, where regional HIV prevalence is highest, still remains far below the national 
target of 80% of adult men.22 We found lower odds of HIV infection among circumcised 
men highlighting that the prevention benefits of this intervention will continue to play an 
important role in addressing the HIV epidemic in Kenya. Further scale-up of HIV 
prevention should aim for universal male circumcision accompanied with sexual risk 
reduction strategies for greater impact in the longer term.
Our results provided important information on geographic areas which require specialized 
attention for HIV prevention. Continued momentum is needed to address persistently high 
levels of HIV infection in Nyanza region. Moreover, the observed increases in HIV 
prevalence among middle-aged and older women in Central region, as well as elevated risk 
of HIV infection among women in urban residences, are areas which require more focused 
strategies.
Our study had several limitations. Because this study was cross-sectional in design, we were 
unable to infer directionality of associations, such as the associations between HIV infection 
and condom use with last sexual partner, widowhood among men, and divorce or separation 
among women. Behaviors, circumcision status, and symptoms of STI were self-reported, 
and associations observed may have been impacted by social desirability bias. Selection bias 
may have been introduced by decisions to exclude North Eastern region from the sampling 
frame because of security concerns. The North Eastern region, however, is relatively 
sparsely populated and had an HIV prevalence of only 0.8% in KAIS 2007,5 and we feel it is 
unlikely that excluding this region affected our results substantially. Differences in HIV 
prevalence between KAIS 2007 and KAIS 2012 could also reflect changes in composition of 
the sample between the two surveys. Compared with KAIS 2007, the sample in KAIS 2012 
had significantly higher proportions of persons who were aged 25–34 years, never married 
or never cohabited, reported secondary education or higher and were from urban 
residences.7 The demographic, behavioral, and biological differences observed among KAIS 
2012 participants in the interview and serologic sample may have also contributed to either 
an underestimation or overestimation of HIV prevalence in 2012, limiting our ability to 
accurately interpret trends in HIV prevalence.
Despite these limitations, KAIS 2012 was a large representative study whose primary 
findings were based on biological samples obtained during the survey. We believe that 
evidence of decreasing HIV prevalence to be encouraging yet underscores the need to 
establish routine and standardized surveillance methods to monitor trends in recently 
acquired HIV infections and HIV-related mortality for a clearer interpretation of the 
epidemiology of HIV in the country. Our data support that substantial interventions are 
needed to improve identification of HIV-infected persons to effectively reach those in need 
of ART for improved survival and continued reductions in transmission risks. Continued 
monitoring of the burden of HIV disease through enhanced surveillance and seeking to 
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assess and respond to factors associated with undiagnosed HIV infection are central to an 
effective response to the HIV epidemic in Kenya.
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TABLE 2
Weighted HIV Prevalence by Demographic, Behavioral, and Biological Indicators, Persons Aged 15–64 
Years, Kenya AIDS Indicator Survey 2012
Select Characteristics Unweighted, N HIV-positive (Unweighted, n*)
Weighted HIV Prevalence % (95% 
CI)
Total 11,626 648 5.6 (4.9 to 6.3)
Sex
 Men 4836 193 4.4 (3.6 to 5.2)
 Women 6790 455 6.9 (6.0 to 7.7)
Age group, yrs
 15–19 1912 17 1.0 (0.5 to 1.6)
 20–24 1907 58 3.1 (2.2 to 4.0)
 25–29 1786 112 6.3 (4.8 to 7.7)
 30–34 1424 97 6.6 (5.2 to 8.0)
 35–39 1222 108 8.7 (6.7 to 10.7)
 40–44 985 90 9.3 (7.1 to 11.6)
 45–49 715 66 9.8 (7.1 to 12.5)
 50–54 735 60 8.4 (6.3 to 10.5)
 55–59 523 24 4.4 (2.4 to 6.4)
 60–64 417 16 4.0 (2.0 to 6.1)
Highest educational attainment
 No primary education 1338 44 3.6 (2.4 to 4.8)
 Incomplete primary education 988 46 5.0 (3.2 to 6.7)
 Completed primary education 3694 223 6.0 (4.9 to 7.0)
 Completed secondary education or higher 5606 335 5.8 (4.9 to 6.7)
Region
 Nairobi 1314 67 4.9 (3.7 to 6.1)
 Central 1423 60 3.8 (2.7 to 4.9)
 Coast 1462 66 4.3 (3.0 to 5.6)
 Eastern North 1061 29 2.1 (1.0 to 3.2)
 Eastern South 1260 46 3.9 (2.4 to 5.3)
 Nyanza 1631 242 15.1 (11.4 to 18.8)
 North Rift 1036 37 3.1 (2.0 to 4.2)
 South Rift 1031 42 4.3 (2.7 to 5.8)
 Western 1408 59 4.7 (3.0 to 6.5)
Residence
 Rural 7501 373 5.1 (4.3 to 5.9)
 Urban 4125 275 6.5 (5.4 to 7.7)
Wealth index
 Poorest 2434 97 4.2 (2.9 to 5.4)
 Second 2497 153 6.5 (4.9 to 8.1)
 Third 2318 137 6.0 (4.6 to 7.4)
 Fourth 2177 159 6.8 (5.3 to 8.3)
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Select Characteristics Unweighted, N HIV-positive (Unweighted, n*)
Weighted HIV Prevalence % (95% 
CI)
 Richest 2200 102 4.6 (3.7 to 5.6)
Marital status
 Never married/never cohabited 3291 58 1.8 (1.3 to 2.3)
 Ever widowed 894 165 20.0 (16.2 to 23.7)
 Separated or divorced 739 83 10.9 (8.4 to 13.4)
 Currently married or cohabiting—
polygamous
753 68 9.7 (6.4 to 13.1)
 Currently married or cohabiting—
monogamous
5945 274 4.8 (4.0 to 5.7)
Behavioral indicators
 Ever had sexual intercourse
  No 1507 10 0.9 (0.3 to 1.6)
  Yes 10,097 636 6.3 (5.5 to 7.1)
 Lifetime number of partners
  1 3263 128 3.8 (3.0 to 4.6)
  2–3 3575 236 6.1 (5.1 to 7.1)
  4+ 2550 208 8.2 (6.8 to 9.6)
  Do not know 620 62 10.6 (7.6 to 13.7)
 Sexually active in the past 12 mo
  No 3420 175 5.2 (4.3 to 6.0)
  Yes 8206 473 5.8 (5.0 to 6.7)
 No. partners in the past 12 mo†
  1 7290 403 5.6 (4.7 to 6.5)
  2+ 830 65 7.4 (5.3 to 9.4)
 Used a condom with last partner in the past 12 mo†
  No 6886 291 4.2 (3.5 to 4.9)
  Yes 1256 179 14.0 (11.1 to 17.0)
 HIV risk perception
  No risk 4213 89 2.1 (1.6 to 2.7)
  Low risk 4240 151 3.5 (2.8 to 4.2)
  Moderate risk 1023 59 5.4 (3.9 to 6.9)
  Great risk 457 41 9.2 (6.2 to 12.2)
Most-at-risk behaviors
 Ever injected drugs for pleasure
  No 11,617 647 5.6 (4.9 to 6.3)
  Yes 9 1 ‡
 Ever had anal sex
  No 9908 621 6.3 (5.5 to 7.0)
  Yes 189 15 8.9 (4.6 to 13.1)
 Ever received money, gifts, or goods in exchange for sex
  No 9716 600 6.2 (5.4 to 7.0)
  Yes 381 36 9.5 (6.1 to 12.8)
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Select Characteristics Unweighted, N HIV-positive (Unweighted, n*)
Weighted HIV Prevalence % (95% 
CI)
 Ever gave money, gifts, or goods in 
exchange for sex (men only)
  No 3415 141 4.5 (3.5 to 5.5)
  Yes 684 48 6.9 (4.7 to 9.1)
Biologic indicators
 Reported STI symptoms in the past 12 mo
  No 9484 562 5.9 (5.2 to 6.7)
  Yes 613 74 12.5 (9.0 to 16.0)
 Ever been tested for HIV
  No 3121 72 2.5 (1.9 to 3.2)
  Yes 8463 574 6.9 (6.0 to 7.7)
 Circumcised (men only)
  No 441 70 16.5 (12.7 to 20.2)
  Yes 4395 123 3.1 (2.5 to 3.8)
 Male partner circumcised (women only)
  No 2008 210 10.9 (9.1 to 12.7)
  Yes 4782 245 5.2 (4.4 to 6.0)
*
Because of missing responses, totals may vary between variables.
†
Among persons who reported being sexually active in the past 12 months.
‡
Estimate suppressed due to small sample size (N<25 observations).
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